EMBCV Stock Price, News & Analysis
Company Description
EMBCV (Nasdaq: EMBCV) is a publicly traded drug manufacturers—specialty & generic company in the Healthcare sector. The company has a market capitalization of $1.9B.
EMBCV stock has declined 29.1% over the past year.
This page provides a comprehensive overview of EMBCV stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
EMBCV (EMBCV) stock. Over the past 12 months, the stock has lost 29.1%. At a market capitalization of $1.9B, EMBCV is classified as a small-cap stock with approximately 57.0M shares outstanding.
Latest News
EMBCV has 10 recent news articles. Key topics include conferences, earnings, partnership, dividends. View all EMBCV news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
EMBCV Company Profile & Sector Positioning
EMBCV (EMBCV) operates in the Drug Manufacturers—Specialty & Generic industry within the broader Healthcare sector.
Investors comparing EMBCV often look at related companies in the same sector, including Plus Prods Inc (PLPRF), H Lundbeck (HLUKF), Biocryst Pharmaceuticals Inc (BCRX), Phibro Animal (PAHC), and Avadel Pharmaceu (AVDL). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate EMBCV's relative position within its industry.